Search Results - "Dyson JK"

Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply.

Authors: McPherson S Dyson JK Jopson L et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (7), pp. 976-977. Date of Electronic Publication: 2024 Sep 10.

Publication Type: Letter

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.

Authors: McPherson S Dyson JK Jopson L et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (7), pp. 980-981. Date of Electronic Publication: 2024 Aug 30.

Publication Type: Letter

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process

Editorial: improving in-hospital management of decompensated cirrhosis by a 'care bundle' - hope, frustration and lessons to learn. Authors' reply.

Authors: McPherson S Dyson JK Hudson M

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2017 Mar; Vol. 45 (5), pp. 755-756.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Authors: Jones DEJ Mitchell-Thain R Culver EL et al.

Source: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2026 Apr; Vol. 23 (4), pp. 368-369.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500079 Publication Model: Print Cited Medium: Internet ISSN: 1759-5053 (Electronic) Linking ISSN: 17595045 NLM ISO Abbreviation: Nat Rev Gastroenterol Hepatol Subsets: MEDLINE; In Process

Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis.

Authors: Wong YJ Lam L Soret PA et al.

Corporate Authors: Wong YJ Lam L Soret PA et al.

Source: Journal of hepatology [J Hepatol] 2026 Feb; Vol. 84 (2), pp. 275-283. Date of Electronic Publication: 2025 Oct 03.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Autoimmune hepatitis overlap syndrome: Clinical presentation, treatment response, and disease evolution: Tertiary centre experience.

Authors: Al Alwan, Abduljaleel Altraif, Ibrahim Alghamdi, Hamdan et al.

Source: Saudi Journal of Gastroenterology. May/Jun2026, Vol. 32 Issue 3, p241-250. 10p.

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis-A promising find. Author's reply.

Authors: Biswas S Vaishnav M Shalimar

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 May; Vol. 59 (10), pp. 1302-1303.

Publication Type: Letter; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Fatigue and itch severity in patients with PBC and PSC: Prospective analysis of two large cohorts.

Authors: Kruk, Beata Raszeja‐Wyszomirska, Joanna Krawczyk, Marcin et al.

Source: European Journal of Clinical Investigation. Jul2025, Vol. 55 Issue 7, p1-3. 3p.

Enhancing liver fibrosis measurement: Deep learning and uncertainty analysis across multi-center cohorts.

Authors: Wojciechowska M Malacrino S Windell D et al.

Corporate Authors: Wojciechowska M Malacrino S Windell D et al.

Source: Journal of pathology informatics [J Pathol Inform] 2026 Mar 20; Vol. 21, pp. 100653. Date of Electronic Publication: 2026 Mar 20 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101528849 Publication Model: eCollection Cited Medium: Print ISSN: 2229-5089 (Print) NLM ISO Abbreviation: J Pathol Inform Subsets: PubMed not MEDLINE

Studying serum immunoglobulin levels in metabolic dysfunction-associated steatotic liver disease.

Authors: Abosheaishaa, Hazem Hussein, Emad Ahmad Awad Saleh, Shereen Abou Bakr et al.

Source: Egyptian Liver Journal. 4/15/2026, Vol. 16 Issue 1, p1-8. 8p.

Validation of PBC‐10 in Japanese patients with primary biliary cholangitis.

Authors: Takeuchi, Akihito Abe, Masanori Furukawa, Sachiko et al.

Source: Hepatology Research. Jul2025, Vol. 55 Issue 7, p986-993. 8p.

Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients Background: Primary sclerosing cholangitis (PSC) is often associated with inflammatory bowel disease (IBD). We aimed to compare the clinical presentations and outcomes of PSC in patients with and without IBD in Saudi population. Methods: The medical records of patients with PSC, diagnosed between 2009 and 2020, in a single referral center in Saudi Arabia were reviewed. Primary outcomes included liver-related clinical decompensations, while secondary outcomes encompassed hepatobiliary malignancies, liver-related mortality, and liver transplantation. Results: Among 87 patients, 52 (59.8%) had PSC-IBD and 35 (40.2%) had PSC without IBD. PSC-IBD patients were significantly younger at diagnosis (35.4 ± 13.3 vs. 43.6 ± 12.8 years, P = 0.005). Non-IBD patients exhibited higher rates of diabetes (P = 0.045), hyperlipidemia (P = 0.022), and autoimmune hepatitis (P = 0.008). While clinical presentations were similar, non-IBD patients demonstrated more frequent cytopenia from splenomegaly (31.4% vs. 5.8%, P = 0.001) and hepatic decompensation (37.1% vs. 7.7%, P = 0.001). Bilirubin (P = 0.002) and aspartate aminotransferase (P = 0.042) levels were increased in non-IBD patients, while PSC-IBD patients had higher white blood cell (P = 0.021) and platelet counts (P < 0.001). Liver biopsies were more frequently performed in non-IBD patients (45.7% vs. 19.2%, P = 0.008). Overall mortality was 12.8%, with no difference in median survival time between groups (P = 0.782). Multivariate analysis identified age (hazard ratio [HR]: 1.048, P = 0.044) and MELD-Na (HR: 1.155, P = 0.016) as independent predictors of mortality. Conclusion: In this Saudi cohort, non-IBD PSC patients were diagnosed later and presented with more comorbidities and hepatic decompensation. However, IBD status did not impact overall survival. Older age and higher MELD-Na scores at presentation were signific

Authors: AlGhamdi, Hamdan S. AlYahya, Nawaf M. Bahabri, Ibrahim M. et al.

Source: Saudi Journal of Gastroenterology. Nov/Dec2025, Vol. 31 Issue 6, p356-366. 11p.

A case of pregnancy complicated by caroli disease.

Authors: Wang, Weiwei Qiang, Xiaoteng Cai, Xiufen et al.

Source: BMC Pregnancy & Childbirth. 10/22/2025, Vol. 25 Issue 1, p1-7. 7p.

Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond.

Authors: Qasim, Bushra Kumari, Hina Kashif, Syeda Naveera et al.

Source: Egyptian Liver Journal. 10/15/2025, Vol. 15 Issue 1, p1-14. 14p.

Paraneoplastic Dermatomyositis in Patient with Primary Biliary Cirrhosis and Hepatocellular Carcinoma: A Case Report.

Authors: Neycheva, Stefka Stoyanova, Daniela

Source: American Journal of Case Reports. 10/1/2025, Vol. 26, p1-8. 8p.

Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead.

Authors: Chen Y Chen R Li H et al.

Source: Immunologic research [Immunol Res] 2025 Apr 07; Vol. 73 (1), pp. 67. Date of Electronic Publication: 2025 Apr 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8611087 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0755 (Electronic) Linking ISSN: 0257277X NLM ISO Abbreviation: Immunol Res Subsets: MEDLINE

Atopic dermatitis and non-alcoholic fatty liver disease: current state of evidence and possible pathogenetic correlations.

Authors: Dębicka, Marta Bąk, Aleksandra Walecki, Jerzy et al.

Source: Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii. Apr2025, Vol. 42 Issue 2, p121-124. 4p.

Implementation of a care bundle improves PBC management.

Authors: Smith R Burke L Abbas N et al.

Corporate Authors: Smith R Burke L Abbas N et al.

Source: JHEP reports : innovation in hepatology [JHEP Rep] 2025 Apr 10; Vol. 7 (9), pp. 101422. Date of Electronic Publication: 2025 Apr 10 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: PubMed not MEDLINE

Epidemiology of colonic adenoma and cancer.

Authors: Kim, Dong Hyun¹ (AUTHOR) bono343@naver.com

Source: Clinical Endoscopy. May2026, Vol. 59 Issue 3, p333-344. 12p.

An experimental study on the effect of symptom expectations on mental fatigue and motivation in people with primary biliary cholangitis.

Authors: Buck, Laura Herzberg, Jule Lenaert, Bert et al.

Source: Scientific Reports. 8/26/2025, Vol. 15 Issue 1, p1-10. 10p.